SRx Health Solutions, Inc. (SRXH): Nasdaq/NYSE listing notice — NYSE American accepts SRx Health's compliance plan; listing extended to July 14, 2026

SRx Health Solutions, Inc.

NYSE accepted plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
As of June 30, 2025, stockholders' equity was negative $45.9 million, triggering the listing deficiency.
Company will provide quarterly updates to NYSE during the Plan Period through July 14, 2026.
Previously notified of deficiency on October 14, 2025; plan acceptance avoids immediate delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SRx Health Solutions, Inc. received a nyse_american extension granted notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

Exchange: nyse american
Notice: extension granted
Deficiency: stockholders equity
Rules: 1003(a)(i), 1003(a)(ii)

Exact text from the filing

January 6, 2026, SRx Health Solutions, Inc. (the “Company”), received a notice from the NYSE American (“NYSE”), that NYSE has accepted the Company’s plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. As previously disclosed, NYSE notified the Company on October 14, 2025, that the Company had fallen below the NYSE’s continued listing standard requiring a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-000926

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.